BNP Paribas Financial Markets Buys 140,030 Shares of Corteva, Inc. $CTVA

BNP Paribas Financial Markets increased its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 13.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,188,069 shares of the company’s stock after acquiring an additional 140,030 shares during the period. BNP Paribas Financial Markets owned approximately 0.18% of Corteva worth $79,636,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Drummond Knight Asset Management Pty Ltd bought a new stake in Corteva during the fourth quarter valued at approximately $25,713,000. Alberta Investment Management Corp bought a new stake in Corteva during the third quarter valued at approximately $5,018,000. Avior Wealth Management LLC grew its position in Corteva by 464.7% during the fourth quarter. Avior Wealth Management LLC now owns 32,901 shares of the company’s stock valued at $2,205,000 after buying an additional 27,075 shares during the period. HighTower Advisors LLC grew its position in Corteva by 8.6% during the third quarter. HighTower Advisors LLC now owns 182,643 shares of the company’s stock valued at $12,352,000 after buying an additional 14,436 shares during the period. Finally, Arbejdsmarkedets Tillaegspension bought a new stake in Corteva during the fourth quarter valued at approximately $23,679,000. Institutional investors own 81.54% of the company’s stock.

Corteva Price Performance

NYSE:CTVA opened at $77.71 on Tuesday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. The firm has a market cap of $51.98 billion, a price-to-earnings ratio of 45.71, a price-to-earnings-growth ratio of 2.39 and a beta of 0.59. The company has a 50 day moving average price of $81.32 and a 200-day moving average price of $74.68. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $85.63.

Corteva (NYSE:CTVA) last posted its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The firm had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.64 billion. During the same period in the previous year, the firm earned $1.13 EPS. The business’s quarterly revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities research analysts forecast that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Monday, June 1st will be given a dividend of $0.18 per share. The ex-dividend date of this dividend is Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s payout ratio is presently 42.35%.

Analysts Set New Price Targets

A number of brokerages recently weighed in on CTVA. Wells Fargo & Company upped their target price on shares of Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 21st. Zacks Research lowered shares of Corteva from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 20th. Jefferies Financial Group upped their target price on shares of Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. The Goldman Sachs Group upped their target price on shares of Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a research report on Tuesday, April 14th. Finally, UBS Group upped their price target on shares of Corteva from $88.00 to $90.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Fourteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat, Corteva has a consensus rating of “Moderate Buy” and an average price target of $88.67.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.